Journey Medical (DERM) Operating Income (2020 - 2026)
Journey Medical's (DERM) quarterly Operating Income came in at -$1.5 million in Q1 2026, up 55.11% YoY from -$961871.2 in Q1 2025, and down 236.79% on a QoQ basis from -$443000.0 in Q4 2025.
Journey Medical (DERM) Operating Income (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of Operating Income data on file, last reported at -$1.5 million in Q1 2026.
- Quarterly Operating Income rose 55.11% year-over-year to -$1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.3 million (up 8.26% YoY) and the FY2025 annual result came in at -$8.2 million, up 40.25% from the prior year.
- Operating Income slipped to -$1.5 million in Q1 2026, from -$443000.0 in the prior quarter.
- In the past five years, Operating Income ranged from a high of $17.2 million in Q3 2023 to a low of -$10.1 million in Q1 2024.
- A 5-year average of -$3.1 million and a median of -$2.9 million in 2024 frame the typical range for Operating Income.
- The widest YoY moves for Operating Income: up 281.68% in 2023, down 976.69% in 2023.
- Tracing DERM's Operating Income over 5 years: stood at -$10.0 million in 2022, then surged by 78.95% to -$2.1 million in 2023, then jumped by 206.18% to $2.2 million in 2024, then slumped by 119.83% to -$443000.0 in 2025, then plunged by 236.79% to -$1.5 million in 2026.
- The last three Operating Income figures came in at -$1.5 million (Q1 2026), -$443000.0 (Q4 2025), and -$1.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Journey Medical | 208.13 Mn | 182.48 Mn | 12.37 Mn | 456,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 456,000.00 |
| Mar 31, 2026 | -1.49 Mn |
| Dec 31, 2025 | -443,000.00 |
| Sep 30, 2025 | -1.53 Mn |
| Jun 30, 2025 | -2.88 Mn |
| Mar 31, 2025 | -3.32 Mn |
| Dec 31, 2024 | 2.23 Mn |
| Sep 30, 2024 | -2.89 Mn |
| Jun 30, 2024 | -2.93 Mn |
| Mar 31, 2024 | -10.09 Mn |
| Dec 31, 2023 | -2.10 Mn |
| Sep 30, 2023 | 17.25 Mn |
| Jun 30, 2023 | -7.65 Mn |
| Mar 31, 2023 | -9.56 Mn |
| Dec 31, 2022 | -10.00 Mn |
| Sep 30, 2022 | -9.49 Mn |
| Jun 30, 2022 | -7.14 Mn |
| Mar 31, 2022 | -888,000.00 |
| Dec 31, 2021 | -9.06 Mn |
| Sep 30, 2021 | -12.65 Mn |